P1.091. Cost-Effectiveness of Omeprazole for Preventing Esophageal Strictures After Zargar Grade 2b–3a Corrosive Injury

Clicks: 18
ID: 325966
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #295 of 453 articles by views in diseases of the esophagus : official journal of the international society for diseases of the esophagus

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 453 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Topic Esophageal Cancer: Caustic Ingestion of the Esophagus Background After the acute phase of corrosive esophageal injury, patients with Zargar grade 2b–3a are at high risk of developing strictures. Preventing stricture-related complications is essential due to their significant impact on patient morbidity and healthcare-related financial burden. Methods This study was a post-hoc economic evaluation conducted alongside a randomized controlled trial with a 4-week follow-up. Adult patients with corrosive esophageal injuries were assigned to receive standard treatment alone or standard treatment plus omeprazole. Costs and clinical outcomes were analyzed from both healthcare provider (hospital) and patient perspectives. Direct medical costs were collected, and the incidence of esophageal stricture was recorded. Cost-effectiveness was assessed by comparing average costs per patient and stricture prevention outcomes between the two treatment groups. Results Patients receiving omeprazole in addition to standard treatment had lower average costs and a lower incidence of corrosive esophageal strictures compared with those receiving standard treatment alone. From the healthcare provider perspective, the combined regimen resulted in cost savings of 4,642.30 Baht (USD 128.38) per patient. From the patient perspective, additional cost savings of 5,476.60 Baht (USD 151.44) per patient were observed. Omeprazole demonstrated both clinical benefit and economic advantage over standard treatment alone. Conclusion Omeprazole combined with standard treatment is a cost-saving strategy for preventing esophageal strictures in adult patients with Zargar grade 2b–3a corrosive injuries. This approach may improve patient outcomes while reducing costs for both patients and healthcare providers, supporting its adoption in clinical practice and healthcare policy.
Reference Key
openalex_W7204000192 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Prasit Mahawongkajit
Are you one of these authors? Claim your profile
Journal diseases of the esophagus : official journal of the international society for diseases of the esophagus
Year 2026
DOI
10.1093/dote/doag077.239
URL
https://doi.org/10.1093/dote/doag077.239
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.